Medical specialists from Russian Federation tagged as investigators in clinical trials studying Carcinoma, Non-Small-Cell Lung

Total 30 results

Alexander Fedenko
Seen in:
- Moscow, State Budget Institution National Medical Research Center of Radiology of the Ministry of Heal
Trials:
- NCT03596866 (Principal Investigator)
Conditions:
- ALK+ Advanced NSCLC
Alexander Luft
Seen in:
- Saint Petersburg, Leningrad Regional Clinical Hospital
Trials:
- NCT03596866 (Principal Investigator)
Conditions:
- ALK+ Advanced NSCLC
Alexey V. Smolin
Seen in:
- Moscow, GSK Investigational Site
Trials:
- NCT04475939 (Principal Investigator)
Conditions:
- Lung Cancer, Non-Small Cell
Anastasia Mochalova
Seen in:
- Otradnoye, Moscow, MEDSI
Trials:
- NCT03390686 (Principal Investigator)
Conditions:
- Lung Cancer;
- Non-small Cell Lung Cancer
Daniil Lvovich Stroyakovskiy
Seen in:
- Moscow, GSK Investigational Site
Trials:
- NCT04655976 (Principal Investigator)
Conditions:
- Lung Cancer, Non-Small Cell
Daniil Stroyakovskiy
Seen in:
- Moscow, Moscow City Oncology Hospital Number 62
Trials:
- NCT03596866 (Principal Investigator)
Conditions:
- ALK+ Advanced NSCLC
Daria Saenko
Seen in:
- Pyatigorsk, Clinica UZI 4D, LLC
- Pyatigorsk, LLC "4D Ultrasound Clinic"
- Stavropol, Pyatigorsk, Clinica Ultra Sound Diagnostic 4D
Trials:
- NCT03596866 (Principal Investigator)
- NCT03719313 (Principal Investigator)
- NCT06263881 (Principal Investigator)
Conditions:
Denis Yurevich Yukalchuk
Seen in:
- Irkutsk, Irkutsk Regional Oncology Center
Trials:
- NCT03596866 (Principal Investigator)
Conditions:
- ALK+ Advanced NSCLC
Ekaterina P. Solovyeva
Seen in:
- Arkhangel'skaya Oblast', Arkhangelsk, Arkhangelsk Clinical Oncological Dispensary
Trials:
- NCT04819100 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung
Ekaterina Petrovna Solovyeva
Seen in:
- Arkhangelsk, Arkhangelsk Clinical Oncological Dispensary
Trials:
- NCT04194944 (Principal Investigator)
Conditions:
- Non-Small Cell Lung Cancer
Elena Reutova
Seen in:
- Moscow, N.N. Blokhin Russian Cancer Research Center
Trials:
- NCT03596866 (Principal Investigator)
Conditions:
- ALK+ Advanced NSCLC
Eugeniy Levchenko
Seen in:
- Saint Petersburg, St. Petersburg, Petrov National Medical Research Center of Oncology
Trials:
- NCT04447118 (Principal Investigator)
Conditions:
- Non-squamous NSCLC;
- HER2 Exon 20 Mutation
Evgeniy Fomin
Seen in:
- Murmansk, Murmansk Regional Clinical Hospital
Trials:
- NCT04194944 (Principal Investigator)
Conditions:
- Non-Small Cell Lung Cancer
Evgeny Levchenko
Seen in:
- Saint Petersburg, National medical research center of oncology n. a. N. N. Petrov
Trials:
- NCT04819100 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung
Fedor Moiseenko
Seen in:
- Saint Petersburg, Saint-Petersburg Clinical Research Center of Specialized Types of Medical Care (Oncology)
- Saint Petersburg, Saint-Petersburg, Saint Petersburg Clinical Scientific and Practical Center of Specialized Types of Medical Aid
- St. Petersburg, GSK Investigational Site
Trials:
- NCT04475939 (Principal Investigator)
- NCT03596866 (Principal Investigator)
- NCT04447118 (Principal Investigator)
Conditions:
Guzel Zinnurovna Mukhametshina
Seen in:
- Kazan, Republic Oncology Dispensary of MoH of Republic Tatarstan
Trials:
- NCT04194944 (Principal Investigator)
Conditions:
- Non-Small Cell Lung Cancer
Konstantin Penkov
Seen in:
- Saint Petersburg, Clinical hospital RZD-Medicine of St. Petersburg
Trials:
- NCT04447118 (Principal Investigator)
Conditions:
- Non-squamous NSCLC;
- HER2 Exon 20 Mutation
Maria Kazantseva
Seen in:
- Moscow, Hadassah Medical LTD
- Moskva, Moscow, Hadassah Medical
Trials:
- NCT04819100 (Principal Investigator)
Conditions:
- Carcinoma, Non-Small-Cell Lung
Maria Smagina
Seen in:
- Saint-Petersburg, GSK Investigational Site
Trials:
- NCT04475939 (Principal Investigator)
Conditions:
- Lung Cancer, Non-Small Cell
Marina Matrosova
Seen in:
- Nizhniy Novgorod, GSK Investigational Site
Trials:
- NCT04475939 (Principal Investigator)
Conditions:
- Lung Cancer, Non-Small Cell
Marina Nechaeva
Seen in:
- Arkhangelr, Arkhangelsk, State Institution of Healthcare Arkhangelsk Regional Clinical Oncology Dispensary
- Arkhangelsk, Arkhangelsk Clinical Oncological Dispensary
Trials:
- NCT03596866 (Principal Investigator)
- NCT04447118 (Principal Investigator)
Conditions:
Marina Sekacheva
Seen in:
- Moscow, FSAEI of HE I.M. Sechenov First Moscow State Medical University of the MoH of the RF
- Moscow, First Moscow State Medical University n.a. Sechenov
Trials:
- NCT05608044 (Principal Investigator)
- NCT04194944 (Principal Investigator)
Conditions:
- Metastatic Colorectal Cancer;
- Non-Small Cell Lung Cancer
Mikhail Dvorkin
Seen in:
- Omsk, GSK Investigational Site
- Omsk, Omsk Regional Clinical Oncologic Dispensary
- Omskaya Oblast', Omsk, Budgetary Healthcare Institution of Omsk Region "Clinical Oncology Dispensary"
- Omskaya Oblast, Omsk, Budgetary Healthcare Institution of Omsk Region "Clinical Oncology Dispensary"
Trials:
- NCT04666038 (Principal Investigator)
- NCT03596866 (Principal Investigator)
- NCT05023980 (Principal Investigator)
- NCT04484623 (Principal Investigator)
Conditions:
Nina Mosina
Seen in:
- Saint Petersburg, Saint-Petersburg, Euromedservice
Trials:
- NCT03596866 (Principal Investigator)
Conditions:
- ALK+ Advanced NSCLC
Oleg Lipatov
Seen in:
- Baškortostan, Respublika, Ufa, GBUZ Republican Clinical Oncological Dispensary
Trials:
- NCT04194944 (Principal Investigator)
Conditions:
- Non-Small Cell Lung Cancer
Oleg V Leonov
Seen in:
- Omsk, GSK Investigational Site
Trials:
- NCT04475939 (Principal Investigator)
Conditions:
- Lung Cancer, Non-Small Cell
Rashida Orlova
Seen in:
- Saint Petersburg, Saint Petersburg State Healthcare Institution Municipal Clinical Oncology Dispensary
Trials:
- NCT03596866 (Principal Investigator)
Conditions:
- ALK+ Advanced NSCLC
Sergey Orlov
Seen in:
- Saint Petersburg, Center of Palliative Medicine - Devita
- Saint Petersburg, Eurocityclinic LLC
- Saint-Petersburg, EuroCityClinic
Trials:
- NCT04819100 (Principal Investigator)
- NCT03596866 (Principal Investigator)
- NCT04447118 (Principal Investigator)
Conditions:
Sergey V. Orlov
Seen in:
- Saint-Petersburg, GSK Investigational Site
Trials:
- NCT04475939 (Principal Investigator)
- NCT04655976 (Principal Investigator)
Conditions:
- Lung Cancer, Non-Small Cell
Yulia Makarycheva
Seen in:
- Samara, Research Site
- Samara, State Healthcare Institution Samara Regional Clinical Oncolo
- Samarskaya Oblast', Samara, Samara Regional Clinical Oncology Center
Trials:
- NCT04194944 (Principal Investigator)
- NCT05905939 (Principal Investigator)
Conditions:
- Non-Small Cell Lung Cancer;
- Breast Cancer

Clinical Trials on Carcinoma, Non-Small-Cell Lung

Sidney Kimmel Cancer Center at Thomas Jefferson...
Bristol-Myers Squibb

Completed

Nivolumab, Cisplatin, and Pemetrexed Disodium or Gemcitabine Hydrochloride in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery

Stage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage I Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung Cancer | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma | Non-Squamous Non-Small...

United States
National Cancer Institute (NCI)

Completed

A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC

Stage IIIA Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma

United States
National Cancer Institute (NCI)

Terminated

Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery

Stage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

Lung Non-Squamous Non-Small Cell Carcinoma | Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7

United States, Puerto Rico
National Cancer Institute (NCI)

Terminated

Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer

Stage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery

Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Recurrent Lung Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IA...

United States
M.D. Anderson Cancer Center

Active, not recruiting

Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer

Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage I Lung Non-Small Cell Cancer AJCC v7 | Stage...

United States
University of Southern California
National Cancer Institute (NCI); Society of Thoracic Radiology

Active, not recruiting

Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer

Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma

United States
National Cancer Institute (NCI)

Completed

EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung Cancer

Stage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer

Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Advanced Lung Non-Squamous Non-Small Cell Carcinoma | Metastatic Lung Non-Squamous Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC...

United States

Medical specialists from Russian Federation tagged as investigators in clinical trials studying Carcinoma, Non-Small-Cell Lung

Clinical Trials on Carcinoma, Non-Small-Cell Lung

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations